The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring Study
Abstract
Background— Inflammation (assessed by C-reactive protein [CRP]) and the metabolic syndrome (MetS) are associated with cardiovascular disease (CVD), but population-based data are limited. Methods and Results— We assessed the cross-sectional relations of CRP to the MetS (National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, Adult Treatment Panel III definition) in 3037 subjects (1681 women; mean age, 54 years) and the utility of CRP and the MetS to predict new CVD events (n=189) over 7 years. MetS (≥3 of 5 traits) was present in 24% of subjects; mean age-adjusted CRP levels for those with 0, 1, 2, 3, 4, or 5 MetS traits were 2.2, 3.5, 4.2, 6.0, or 6.6 mg/L, respectively ( P trend <0.0001). In persons with MetS, age-adjusted CRP levels were higher in women than men (7.8 versus 4.6 mg/L; P <0.0001). MetS and baseline CRP were individually related to CVD events (for MetS: age-sex-adjusted hazard ratio [HR], 2.1; 95% CI, 1.5 to 2.8; for highest versus lowest CRP quartile: HR, 2.2; 95% CI, 1.4 to 3.5). Greater risk of CVD persisted for MetS and CRP even after adjustment in a model including age, sex, MetS (HR, 1.8; 95% CI, 1.4 to 2.5), and CRP (HR, 1.9; 95% CI, 1.2 to 2.9). The c-statistic associated with the age- and sex-adjusted model including CRP was 0.72; including MetS, 0.74; and including CRP and MetS, 0.74. Conclusions— Elevated CRP levels are related to insulin resistance and the presence of the MetS, especially in women. Although discrimination of subjects at risk of CVD events using both MetS and CRP is not better than using either phenotype alone, both CRP and MetS are independent predictors of new CVD events.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The MS has been associated with incident CHD and CHD mortality, [5][6][7][8][9][10][11]”
From Diabetes, the Metabolic Syndrome, and Angiographic Progression of Coronary Arterial Disease in Postmenopausal Women (2006) · cites this paper as [10]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465
Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,366
Self-citationRidker, P. M., Buring, J. E., Cook, N. R., & Rifai, N. (2003) · Circulation · doi:10.1161/01.cir.0000055014.62083.05 · Cited by 2,292
Sattar, N., Gaw, A., Scherbakova, O., Ford, I., O’Reilly, D. S. J., Haffner, S. M., Isles, C., Macfarlane, P. W., Packard, C. J., Cobbe, S. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000080897.52664.94 · Cited by 1,506
Schmidt, M. I., Duncan, B. B., Sharrett, A. R., Lindberg, G., Savage, P. J., Offenbacher, S., Azambuja, M. I. R., Tracy, R. P., & HEISS, G. M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01046-6 · Cited by 1,080
Festa, A., D’Agostino, R., Tracy, R. P., & Haffner, S. M. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1131 · Cited by 1,057
Self-citationIs Type II diabetes mellitus a disease of the innate immune system?
Pickup, J. C., & Crook, M. A. (1998) · Diabetologia · doi:10.1007/s001250051058 · Cited by 1,042
Cited by
Sorted by citations
Items 201–300 of 662
Agarwal, S., Jacobs, D. R., Vaidya, D. M., Sibley, C. T., Jorgensen, N. W., Rotter, J. I., Chen, Y. I., Liu, Y., Andrews, J. S., Kritchevsky, S. B., et al. (2012) · Cardiology Research and Practice · doi:10.1155/2012/919425 · Cited by 50
“Our findings parallel similar results where addition of hsCRP to MetS did not lead to improvement in prediction of incident CVD events [29] or atherogenesis [30].”
ResultWethal, T., KJEKSHUS, J. K., Røislien, J., Ueland, T., Andreassen, A. K., Wergeland, R., Aukrust, P., & Fosså, S. D. (2007) · Journal of Cancer Survivorship · doi:10.1007/s11764-007-0012-3 · Cited by 50
“As has been observed more generally [ 24 ], we found that long-term survivors of testicular cancer with metabolic syndrome expressed enhanced inflammation, as was reflected in elevated hsCRP levels.”
ResultAguilar, D. A., Fisher, M. R., O’Connor, C. M., Dunne, M. W., Muhlestein, J. B., Yao, L., Gupta, S., Benner, R. J., Cook, T. D., Edwards, D., et al. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.11.011 · Cited by 50
Oxidative Stress and Atherosclerosis
Kunitomo, M. (2007) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.127.1997 · Cited by 50
Jeppesen, J., Hansen, T. W., Rasmussen, S. L., Ibsen, H., & Torp-Pedersen, C. T. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.12.010 · Cited by 49
Lee, M. J., Jung, C. H., Kang, Y. M., Hwang, J., Jang, J. E., Leem, J., Park, J.-Y., Kim, H.-K., & Lee, W. J. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.04.006 · Cited by 48
Fayh, A. P. T., Lopes, A. L., Fernandes, P. R., Reischak-Oliveira, Á., & Friedman, R. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114512005442 · Cited by 51
Liu, C.-S., Pi-Sunyer, X., Li, C.-I., Davidson, L. E., Li, T., Chen, W. W., Lin, C., Huang, C., & Lin, W.-Y. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.02.015 · Cited by 48
Furuta, M., Shimazaki, Y., Takeshita, T., Shibata, Y., Akifusa, S., Eshima, N., Kiyohara, Y., Ninomiya, T., Hirakawa, Y., Mukai, N., et al. (2013) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.12119 · Cited by 50
“Journal of Clinical Periodontology published by John Wiley & Sons Ltd 743 This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not…”
BackgroundMethodLin, S., Hu, H., Chao, H.-L., Ho, B., Chen, C., Chan, L., Lin, H., Sun, Y., Lin, Y.-Y., Chen, P., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.737441 · Cited by 47
Rhéaume, C., Arsenault, B. J., Dumas, M.-P., Përusse, L., Tremblay, A., Bouchard, C., Poirier, P., & Després, J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2432 · Cited by 47
Beavers, K. M., Hsu, F., Houston, D. K., Beavers, D. P., Harris, T. B., Hue, T. F., Kim, L. J., Koster, A., Penninx, B. W. J. H., Simonsick, E. M., et al. (2012) · The Journals of Gerontology Series A · doi:10.1093/gerona/gls213 · Cited by 47
“Chronic knee pain (%) 255 (14) 194 (19) <.”
Abd, T. T., Eapen, D. J., Bajpai, A., Goyal, A., Dollar, A. L., & Sperling, L. S. (2011) · Current Atherosclerosis Reports · doi:10.1007/s11883-011-0164-5 · Cited by 47
Ma, Y., Olendzki, B. C., Hafner, A. R., Chiriboga, D. E., Culver, A. L., Andersen, V., Merriam, P. A., & Pagoto, S. (2006) · Nutrition · doi:10.1016/j.nut.2006.08.006 · Cited by 46
Vikram, N. K., Misra, A., Pandey, R. M., Dwivedi, M., Luthra, K., Dhingra, V., & Talwar, K. K. (2006) · PubMed · Cited by 47
Darroudi, S., Fereydouni, N., Tayefi, M., Ahmadnezhad, M., Zamani, P., Tayefi, B., Kharazmi, J., Tavalaie, S., Heidari‐Bakavoli, A., Azarpajouh, M. R., et al. (2018) · BioFactors · doi:10.1002/biof.1459 · Cited by 47
Elevated levels of C-reactive protein as a risk factor for Metabolic Syndrome in Indians
Mahajan, A., Jaiswal, A., Tabassum, R., Podder, A., Ghosh, S., Madhu, S. V., Mathur, S. K., Tandon, N., & Bharadwaj, D. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.10.031 · Cited by 46
“[5] Rutter MK, Meigs JB, Sullivan LM, et al.”
BackgroundMetabolic syndrome and its association with morbidity and mortality
Ardern, C. I., & Janssen, I. (2007) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h06-099 · Cited by 46
Effects of Ramadan Fasting on Health and Athletic Performance
Chtourou, H. (2015) · OMICS International eBooks · doi:10.4172/978-1-63278-030-0-031 · Cited by 45
Dupuy, A., Jaussent, I., Lacroux, A., Durant, R., Cristol, J., & Delcourt, C. (2007) · Gerontology · doi:10.1159/000103555 · Cited by 46
“C-reactive protein (CRP) is one of the most sensitive acute-phase proteins and is widely used to evidence and estimate the severity of acute inflammation. Low-grade systemic inflammation associated with a moderate increase in CRP is now recognized as a strong and independent predictor of cardiovascular risk in middle-…”
BackgroundPalacios, R., Santos, J., González, M., Ruiz, J., & Márquez, M. (2007) · International Journal of STD & AIDS · doi:10.1258/095646207780132415 · Cited by 46
Lung function, coronary artery calcification, and metabolic syndrome in 4905 Korean males
Park, H. Y., Lim, S. Y., Hwang, J. H., Choi, J., Koh, W., Sung, J., Suh, G. Y., Chung, M. P., Kim, H., Choe, Y. H., et al. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.02.024 · Cited by 45
Chiu, F.-H., Chuang, C. H., Li, W.-C., Weng, Y.-M., Fann, W., Lo, H.-Y., Sun, C., & Wang, S.-H. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-40 · Cited by 45
“Furthermore, CRP has been related to metabolic syndrome in several studies [2,6], and its production is influenced by leptin [7].”
BackgroundSaltevo, J. T., Laakso, M., Jokelainen, J. J., Keinanen-Kiukaanniemi, S. M., Kumpusalo, E., & Vanhala, M. J. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.831 · Cited by 45
Association of chronic viral hepatitis B with insulin resistance
Lee, J. G. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i42.6120 · Cited by 44
Metabolic score as a novel approach to assessing preeclampsia risk
Mazar, R. M., Srinivas, S. K., Sammel, M. D., Andrela, C. M., & Elovitz, M. A. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.07.014 · Cited by 44
Denız, F., Katırçıbaşı, M. T., Pamukçu, B., Binici, S., & Sanisoğlu, S. Y. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02711.x · Cited by 44
The metabolic syndrome: a call to action
Gotto, A. M., Blackburn, G. L., DAILEY, G. E., Garber, A. J., Grundy, S. M., Sobel, B. E., & Weir, M. R. (2005) · Coronary Artery Disease · doi:10.1097/00019501-200602000-00013 · Cited by 44
Su, Z., Efremov, L., & Mikolajczyk, R. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.09.002 · Cited by 49
Sander, K., Horn, C. S., Briesenick, C., & Sander, D. (2007) · Stroke · doi:10.1161/strokeaha.106.481531 · Cited by 44
Thieringer, R., & Hermanowski‐Vosatka, A. (2005) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.3.5.911 · Cited by 43
Effects of lifestyle interventions on inflammatory markers in the metabolic syndrome
Beavers, K. M. (2010) · Frontiers in Bioscience-Scholar · doi:10.2741/s142 · Cited by 45
“9(9:0)/42(40-52) 45-60 min aerobic + resistance activity 3 times/wk”
BackgroundInfluentialMetabolic syndrome and underlying genetic determinants-A systematic review
Rana, S., Ali, S., Wani, H. A., Mushtaq, Q. D., Sharma, S., & Rehman, M. U. (2022) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-022-01009-z · Cited by 51
Diabetes and Cardiovascular Disease: Insights from the Framingham Heart Study
Qazi, M., & Malik, S. (2013) · Global Heart · doi:10.1016/j.gheart.2012.12.008 · Cited by 45
“Similarly, other studies have shown that elevated levels of C-reactive protein [21] and homocysteine [16] are both associated with insulin resistance and an increased risk of CVD.”
ResultAssociation between elevated liver enzymes and metabolic syndrome among Thai adults
Perera, S., Lohsoonthorn, V., Jiamjarasrangsi, W., Lertmaharit, S., & Williams, M. A. (2008) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2008.04.012 · Cited by 42
Girman, C. J., Dekker, J. M., Rhodes, T., Nijpels, G., Stehouwer, C. D. A., Bouter, L. M., & Heine, R. J. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi229 · Cited by 41
“metabolic syndrome has been shown by several studies (12, 16, 24, 28, 34, 54) and is intuitive, because risk is a continuum and not dichotomous.”
MethodMetabolic Syndrome features and risk of neural tube defects
Ray, J. G., Thompson, M. D., Vermeulen, M. J., Meier, C., WYATT, P. R., Wong, P.-Y., Summers, A. M., Farrell, S. A., & Cole, D. E. C. (2007) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-7-21 · Cited by 41
“Recent evidence from the Framingham Offspring Study suggests that combining hsCRP in a model of MetSyn does not improve the ability to predict cardiovascular disease risk [ 21 ].”
BackgroundLiang, K., Tsai, I., Lee, W., Lee, I., Lee, W., Lin, S., Wan, C., Fu, C., Ting, C.-T., & Sheu, W. H. (2011) · Obesity · doi:10.1038/oby.2011.155 · Cited by 41
“Moreover, reports revealed that MetS women had a higher hs-CRP expression than MetS men (13,29), implying a gender difference of inflammation.”
BackgroundAssociation between dietary glycemic index, glycemic load, and high-sensitivity C-reactive protein
Griffith, J. A., Ma, Y., Chasan‐Taber, L., Olendzki, B. C., Chiriboga, D. E., Stanek, E. J., Merriam, P. A., & Ockene, I. S. (2008) · Nutrition · doi:10.1016/j.nut.2007.12.017 · Cited by 41
“High-sensitivity C-reactive protein (hs-CRP), a marker of inflammation, has been recognized as a risk factor for future cardiac events [4–12].”
Akıncı, G., Akıncı, B., Coşkun, Ş., Bayındır, P., Hekimsoy, Z., & Özmen, B. (2008) · HORMONES · doi:10.1007/bf03401507 · Cited by 41
Postprandial insulin resistance as an early predictor of cardiovascular risk.
Lautt, W. W. (2007) · PubMed Central · Cited by 41
Joaquín, C., Aguilera, E., Granada, M. L., Pastor, M. C., Salinas, I., Alonso, N., & Sanmartı́, A. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0554 · Cited by 40
Inverse Association Between Total Bilirubin and Metabolic Syndrome in Rural Korean Women
Kwon, K.-M., Kam, J.-H., Kim, M. Y., Kim, M., Chung, C. H., Kim, J.-K., Linton, J. A., Eom, A., Koh, S. B., & Kang, H. (2011) · Journal of Women s Health · doi:10.1089/jwh.2010.2453 · Cited by 40
“CRP, an inflammatory indicator and an important risk factor for MetS, was also adjusted for in logistic regression analysis.(4) In addition, menopausal status was adjusted to control the effects of female hormones on MetS in logistic regression analysis, as they are closely associated with MetS and insulin resistance.”
Ishikawa, S., Kayaba, K., Gotoh, T., Nakamura, Y., Kario, K., Ito, Y., & Kajii, E. (2007) · Journal of Epidemiology · doi:10.2188/jea.17.120 · Cited by 40
Lee, J. E., Choi, S.-Y.-O., Huh, W., Kim, Y.-G., Kim, D. J., & Oh, H. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2007.04.020 · Cited by 44
Gandhi, R., Razak, F. A., Tso, P., Davey, J. R., & Mahomed, N. N. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090282 · Cited by 39
Gandhi, R., Razak, F. A., Tso, P., Davey, J. R., & Mahomed, N. N. (2009) · The Journal of Arthroplasty · doi:10.1016/j.arth.2009.02.005 · Cited by 39
“Moreover, patients with MS have been shown to be in a chronically elevated prothrombotic state [3-5].”
BackgroundSerum amylase and risk of the metabolic syndrome in Korean adults
Lee, J. G., Park, S. W., Cho, B. M., Lee, S. Y., Kim, Y. J., Jeong, D. W., Yi, Y. H., & Cho, Y. H. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.06.023 · Cited by 39
The Role of Endocannabinoid System Blockade in the Treatment of the Metabolic Syndrome
Kakafika, A. I., Mikhailidis, D. P., Karagiannis, A. I., & Athyros, V. G. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007299358 · Cited by 39
Mellen, P. B., Cefalu, W. T., & Herrington, D. M. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000191656.71812.7c · Cited by 38
Kalyan, S., Goshtesabi, A., Sarray, S., Joannou, A., & Almawi, W. Y. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-021860 · Cited by 38
Nishida, H., Horio, T., Suzuki, Y., Iwashima, Y., Tokudome, T., Yoshihara, F., Nakamura, S., & Kawano, Y. (2010) · Cytokine · doi:10.1016/j.cyto.2010.12.005 · Cited by 38
Characteristics of Obesity and Its Related Disorders in China
Jia, W., Wang, C., Jiang, S., & Pan, J. (2010) · Biomedical and Environmental Sciences · doi:10.1016/s0895-3988(10)60025-6 · Cited by 43
Rudnicka, A. R., Rumley, A., Whincup, P. H., Lowe, G. D. O., & Strachan, D. P. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04517.x · Cited by 37
Mónica Acevedo, B., Arnaíz, P., Salesa Barja, Y., Claudia Bambs, S., Berrios, X., Guzmán, B., Carvajal, J., Cassis, B., & Navarrete, C. (2007) · Revista Española de Cardiología · doi:10.1157/13111237 · Cited by 37
Suzuki, T., Voeks, J. H., Zakai, N. A., Jenny, N. S., Brown, T. M., Safford, M. M., LeWinter, M. M., Howard, G., & Cushman, M. (2014) · Diabetes Care · doi:10.2337/dc13-2059 · Cited by 37
Yang, T., Chu, C., Hsieh, P.-C., Hsu, C., Chou, Y., Yang, S.-H., Bai, C., You, S., Hwang, L., Chung, T.-C., et al. (2012) · Endocrine · doi:10.1007/s12020-012-9743-7 · Cited by 37
Biomarkers of Metabolic Syndrome: Biochemical Background and Clinical Significance
Robberecht, H. J., & Hermans, N. (2016) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0113 · Cited by 38
“Ad-ditionally to the traditional markers, white blood cell (WBC) count, 17 high-sensitivity C-reactive protein 18 (hsCRP; as a marker of inflammation), homeostasis model assessment of insulin resistance (HOMA-IR) index 19 (as a marker of insulin resistance), homocysteine 21 (as a marker of…”
Effects of Yoga on Sexual Function in Women with Metabolic Syndrome: A Randomized Controlled Trial
Kim, H.-N., Ryu, J., Kim, K. S., & Song, S.-W. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12283 · Cited by 38
Yoshida, T., Kaneshi, T., Shimabukuro, T., Sunagawa, M., & Ohta, T. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2856 · Cited by 37
Association Among C-Reactive Protein, Fatty Liver Disease, and Cardiovascular Risk
Lizardi-Cervera, J., Chávez-Tapia, N. C., Pérez-Bautista, O., Ramos, M. H., & Uribe, M. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9262-6 · Cited by 37
“cardiovascular problems [33], but it is unknown whether this risk extends to subjects with NAFLD.”
N-Glycosylation Profiles of Immunoglobulin G and Future Cardiovascular Events
Hoshi, R. A., Plavša, B., Liu, Y., Trbojević‐Akmačić, I., Glynn, R. J., Ridker, P. M., Cummings, R. D., Gudelj, I., Lauc, G., Demler, O., et al. (2024) · Circulation Research · doi:10.1161/circresaha.123.323623 · Cited by 37
“57 58–68 Correlations between IgG N -glycans and clinical biomarkers were concordant in terms of sign and magnitude across studies for most IgG-GPs, and several were significant in both cohorts (Figure S5).”
BackgroundZuliani, G., Morieri, M. L., Volpato, S., Maggio, M. G., Cherubini, A., Francesconi, D., Bandinelli, S., Paolisso, G., Guralnik, J. M., & Ferrucci, L. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.05.959 · Cited by 36
Kim, M. S., Shigenaga, J. K., Moser, A. H., Feingold, K. R., & Grünfeld, C. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500217-jlr200 · Cited by 36
Gharipour, M., Ramezani, M. A., Sadeghi, M., Khosravi, A., Masjedi, M., Khosravi‐Boroujeni, H., Rafieian‐Kopaei, M., & Sarrafzadegan, N. (2013) · Europe PMC (PubMed Central) · Cited by 35
Gender-Specific Association Between the Metabolic Syndrome and Arterial Stiffness in 8,300 Subjects
Weng, C., Yang, K., Tang, X., Huang, Z., Huang, L., Chen, W., Yuan, H., Chen, F., Chen, Z., & Yang, P. (2013) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3182732e97 · Cited by 35
“1).(1,4) Before onset of CVD, the MetS is often present.”
BackgroundFiber's impact on high‐sensitivity C‐reactive protein levels in cardiovascular disease
Butcher, J. L., & Beckstrand, R. L. (2010) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2010.00555.x · Cited by 36
Hansen, T., Ahlström, H. K., Söderberg, S., Hulthe, J., Wikström, J., Lind, L., & Johansson, L. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.11.007 · Cited by 35
Barrios, V., Escobar, C., Calderón, A., Llisterri, J. L., Alegría, E., Muñiz, J., & Matalí, A. (2007) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4564.2007.06313.x · Cited by 35
Soriano‐Maldonado, A., Aparicio, V. A., Félix-Redondo, F. J., & Fernandez-Berges, D. J. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.07.253 · Cited by 35
Kömürcü-Bayrak, E., Erginel‐Ünaltuna, N., Onat, A., Ozsait, B., Eklund, C., Hurme, M., Mononen, N., Laaksonen, R., Hergenç, G., & Lehtimäki, T. J. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.03.030 · Cited by 34
Fiber intake and inflammation in type 1 diabetes
Bernaud, F. S. R., Beretta, M. V., do Nascimento, C., Escobar, F. T., Gross, J. L., de Azevedo, M. J., & Rodrigues, T. D. C. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-66 · Cited by 34
Deetman, P. E., Bakker, S. J. L., & Dullaart, R. P. F. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-166 · Cited by 34
van Wijk, D. F., Boekholdt, S. M., Arsenault, B. J., Ahmadi‐Abhari, S., Wareham, N. J., Stroes, E. S. G., & Khaw, K. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002823 · Cited by 33
“prevalence of the metabolically healthy but obese phenotype was somewhat higher in our population compared with previous studies,(19) probably because we defined abdominal obesity by waist circumference, whereas other studies used other measures to determine obesity (eg, body mass index).(12) It must be noted that in…”
ResultHong, G., Gao, P., Chen, Y., Xia, Y. Y., Ke, X., Shao, X., Xiong, C., Chen, H.-S., Xiao, H., Ning, J., et al. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s241774 · Cited by 33
Long-term C-Reactive Protein Variability and Prediction of Metabolic Risk
Chen, T.-H., Gona, P. N., Sutherland, P. A., Benjamin, E. J., Wilson, P. W. F., Larson, M. G., Vasan, R. S., & Robins, S. J. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.08.023 · Cited by 33
Self-citationNatal, C., Restituto, P., Iñigo, C., Colina, I., Dı́ez, J., & Varo, N. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2491 · Cited by 33
Intracranial atherosclerotic stroke: Specific focus on the metabolic syndrome and inflammation
Bang, O. Y. (2006) · Current Atherosclerosis Reports · doi:10.1007/s11883-006-0012-1 · Cited by 33
Sex differences and cardiovascular risk
Cordero, A., & Alegria, E. (2006) · Heart · doi:10.1136/hrt.2005.069187 · Cited by 33
C-reactive protein and cardiovascular diseases: a synthesis of studies based on different designs
Liu, C., & Li, C. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad116 · Cited by 37
Group of Serum Inflammatory Markers and Periodontitis–Metabolic Syndrome Coexistence in Koreans
Han, D., Shin, H., Kim, M., Paek, D., & Kim, H. (2011) · Journal of Periodontology · doi:10.1902/jop.2011.110304 · Cited by 32
Metabolic syndrome, cardiovascular risk and screening for subclinical atherosclerosis
Malik, S., & Wong, N. D. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.7.3.273 · Cited by 32
Clinical Use of the Metabolic Syndrome: Why the Confusion?
Blaha, M. J., & Elasy, T. A. (2006) · Clinical Diabetes · doi:10.2337/diaclin.24.3.125 · Cited by 32
Vidula, H., Liu, K., Criqui, M. H., Szklo, M., Allison, M., Sibley, C. T., Ouyang, P., Tracy, R. P., Chan, C., & McDermott, M. M. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.08.044 · Cited by 32
Metabolic Syndrome, C-Reactive Protein and Increased Arterial Stiffness in Japanese Subjects
Saijo, Y., Yoshioka, E., FUKUI, T., Kawaharada, M., & Kishi, R. (2006) · Hypertension Research · doi:10.1291/hypres.29.589 · Cited by 32
“However, another report insisted that combining CRP and MS data added little to overall cardiovascular disease risk prediction (14).”
BackgroundUrinary PGDS levels are associated with vascular injury in type 2 diabetes patients
Yoshikawa, R., Wada, J., Seiki, K., Matsuoka, T., Miyamoto, S., Takahashi, K., Ota, S., Taniai, K., Hida, K., Yamakado, M., et al. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.09.004 · Cited by 31
Multiple biomarkers and their relative contributions to identifying metabolic syndrome
Lee, J. G., Lee, S. Y., Kim, Y. J., Jin, H. K., Cho, B. M., Kim, Y. J., Jeong, D. W., Park, H. J., & Kim, J. E. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.07.006 · Cited by 31
Association between paraoxonase-1 gene polymorphisms and risk of metabolic syndrome
Kordi-Tamandani, D. M., Hashemi, M. M., Sharifi, N., Kaykhaei, M. A., & Torkamanzehi, A. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-0819-x · Cited by 31
“In addition, MS has also been reported to be linked with elevated serum high-sensitive C-reactive protein (hsCRP) [5, 6], endothelial dysfunction [7], increased carotid intima media thickness (IMT) [8], cardiovascular disorder and mortality [9, 10].”
BackgroundLin, W.-Y., Lai, M.-M., Li, C., Lin, C., Li, T., Chen, C., Lin, T., & Liu, C.-S. (2009) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e603 · Cited by 30
The influence of inflammation on cardiovascular disease in women
Kottilil, S., & Mathur, P. (2022) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2022.979708 · Cited by 32
Lavie, L., & Lavie, P. (2007) · Chronobiology International · doi:10.1080/07420520601139797 · Cited by 30
“Increased BMI, dyslipidemia, hyperglycaemia, and decreased HDL are components of the “metabolic syndrome,” of which CRP has been suggested to be an additional component (Rutter et al., 2004).”
BackgroundMay, A., & Wang, T. J. (2007) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.7.6.793 · Cited by 31
C-Reactive Protein and Metabolic Syndrome in Elderly Women
Hassinen, M., Lakka, T. A., Komulainen, P., Gylling, H., Nissinen, A. M., & Rauramaa, R. (2006) · Diabetes Care · doi:10.2337/diacare.29.04.06.dc05-2508 · Cited by 30
“Cross-sectional studies have found associations of CRP with metabolic syndrome (6–9) and its components, including obesity (10), insulin resistance (6,7,10), dyslipidemia (10), elevated blood pressure (11), and endothelial dysfunction (10).”
BackgroundZaghloul, A., Albukhari, T. A., AL-Pakistani, H. A., Shalaby, M., Halawani, S. H., Bajuaifer, N., & Teama, S. H. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.09.007 · Cited by 29
Siegel, G., Ermilov, E. A., Knes, O., & Rodríguez, M. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.10.023 · Cited by 29
Demarble, J. B., Moskowitz, D. S., Tardif, J., & D’Antono, B. (2014) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2014.02.010 · Cited by 28
The Framingham Study on Cardiovascular Disease Risk and Stress-Defenses: A Historical Review
Abohelwa, M., Kopel, J. J., Shurmur, S. W., Ansari, M. M., Awasthi, S., & Awasthi, S. (2023) · Journal of Vascular Diseases · doi:10.3390/jvd2010010 · Cited by 43
“The simultaneous occurrence of HTN and obesity is a characteristic of metabolic syndrome [28,32,164,337].”
BackgroundAli, N., Samadder, M., Shourove, J. H., Taher, A., & Islam, F. (2023) · Scientific Reports · doi:10.1038/s41598-023-46943-x · Cited by 29
“It has been demonstrated that BMI is associated with an increased risk of developing MetS in adulthood 39 .”
BackgroundRizzo, M., Rizvi, A. A., Rini, G. B., & Berneis, K. K. (2008) · Acta Diabetologica · doi:10.1007/s00592-008-0057-4 · Cited by 29
“Intriguingly, the role of CRP in the prediction of cardiovascular events [29, 30] and its association with insulin resistance [31] and hyperinsulinaemia [32] may provide clues to more definitive answers.”
BackgroundAssociation between fasting glucose and C-reactive protein in a Japanese population: the Minoh study
Nakanishi, N., SHIRAISHI, T., & Wada, M. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.11.009 · Cited by 29
Metadata
- Authors
- Rutter, M. K., Meigs, J. B., Sullivan, L. M., D’Agostino, R. B., & Wilson, P. W. F.
- Affiliations
- Boston University (US)
- Venue
- Circulation
- Published
- 2004-07-27
- Volume
- 110
- Issue
- 4
- Pages
- 380-385
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1983997573
- Cited by
- 664
- References
- 36
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 9 · 2023: 15 · 2022: 19 · 2021: 9 · 2020: 8 · 2019: 11 · 2018: 15 · 2017: 13 · 2016: 19 · 2015: 20 · 2014: 36 · 2013: 36 · 2012: 26
- FWCI
- 48.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- National Institutes of Health (n01hc25195-41-0-1)
- National Heart, Lung, and Blood Institute (R01HL073272, N01‐HC25195, R01-HL 073272-01)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- C-reactive protein, metabolic syndrome, cardiovascular risk prediction, inflammation, insulin resistance, sex differences, Framingham Offspring Study, cardiovascular events, risk discrimination, cardiovascular risk in women, NCEP ATP III criteria, Framingham risk score, Framingham risk equation
- MeSH terms
- Adult, Aged, Aged, 80 and over, C-Reactive Protein, Cardiovascular Diseases, Cross-Sectional Studies, Female, Follow-Up Studies, Humans, Inflammation, Insulin Resistance, Male, Middle Aged, Predictive Value of Tests, Risk, Sex Factors, Cohort Studies, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review